Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Fredun Pharmaceuticals Limited (NSE: FREDUN), ISIN INE194R01017 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
FREDUN last traded at ₹1395.35 (+0.90%), with a 52-week range of ₹396.29 to ₹1600.00 (as of 23 Sep 2026).
Shareholding as of Jun 2026: promoters 44.57%, FIIs 1.06%, DIIs 2.94%, mutual funds 0.00%.
EquiSense Score (ECS): 78/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.